<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03584152</url>
  </required_header>
  <id_info>
    <org_study_id>46945</org_study_id>
    <nct_id>NCT03584152</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Management in Rhinoplasty</brief_title>
  <official_title>Postoperative Pain Management in Rhinoplasty: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the study is to determine adequacy of postoperative pain control after
      nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to
      Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess
      the degree of pain, the participants will score the intensity of their pain on a visual
      analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and
      postoperatively (to be documented before each dose) for the duration of the prescribed
      medications .

      Additionally, the study will also seek to track:

        1. The total number of pills each patients consume from the prescribed 5 day regimen.

        2. Any associated side effects.

        3. Additional pain medications prescribed in case of inadequate pain control,
           postoperatively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From this study, the investigators hope to learn the following:

        1. Is adequate postoperative pain management after nasal surgery achieved with opioid or
           non-opioid drugs?

        2. If opioid drugs are required for adequate pain control postoperatively, is it possible
           to reduce the number of days the drugs are prescribed for?

        3. What are the common side effect profiles of the included drugs?

      In light of the current opioid epidemic in the country, it is important the the physicians
      explore the utility of drugs other than opioids for adequate postoperative pain management.
      Also, reducing the dosage and/or number of prescribed opioid drugs lessens the propensity for
      misuse of physician prescribed opioid medications.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 9, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity Visual Analog Scale (VAS)- 0-100 (0- no pain and 100- most severe pain)</measure>
    <time_frame>5 days</time_frame>
    <description>Self reported pain intensity at every prescribed dose for a period of 5 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects of pain medications</measure>
    <time_frame>5 days</time_frame>
    <description>Self reported side effects of prescribed medications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>DRUG ARM A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Norco 5Mg-325Mg Tablet, administered orally every 4 hours for 5 days total</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DRUG ARM B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tylenol 325Mg Caplet, administered orally every 4 hours for 5 days total. Ibuprofen 200 mg administered orally every 4 hours for 5 days total.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norco 5Mg-325Mg Tablet</intervention_name>
    <description>Opioid Analgesics</description>
    <arm_group_label>DRUG ARM A</arm_group_label>
    <other_name>Lortab</other_name>
    <other_name>Vicodin</other_name>
    <other_name>Hycet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tylenol 325Mg Caplet</intervention_name>
    <description>Non opioid analgesics</description>
    <arm_group_label>DRUG ARM B</arm_group_label>
    <other_name>Acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 200 mg</intervention_name>
    <description>Non opioid analgesics</description>
    <arm_group_label>DRUG ARM B</arm_group_label>
    <other_name>Advil</other_name>
    <other_name>Motrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age of 18 years

          -  Able to speak and understand english.

          -  Undergoing rhinoplasty for cosmetic purposes

          -  Undergoing rhinoplasty for treatment of nasal obstruction

        Exclusion Criteria:

          -  Less than 18 years of age

          -  Cannot speak and understand english

          -  Patients not undergoing nasal surgery.

          -  Women will be excluded if they are either pregnant or lactating as this population
             does not undergo nasal surgery at our center.

          -  Patients with any known allergies to the class of pain medications used in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SAM P Most, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Facial Plastic and Reconstructive Surgery Clinic</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Patel S, Sturm A, Bobian M, Svider PF, Zuliani G, Kridel R. Opioid Use by Patients After Rhinoplasty. JAMA Facial Plast Surg. 2018 Jan 1;20(1):24-30. doi: 10.1001/jamafacial.2017.1034.</citation>
    <PMID>29121158</PMID>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 27, 2018</study_first_submitted>
  <study_first_submitted_qc>July 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Sam P. Most</investigator_full_name>
    <investigator_title>Chief, Division of Facial Plastic and Reconstructive Surgery</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Rhinoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

